Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:dateCreated |
1990-7-20
|
pubmed:language |
jpn
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Feb
|
pubmed:issn |
0047-1852
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
48 Suppl
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
22-6
|
pubmed:dateRevised |
2011-7-27
|
pubmed:meshHeading |
pubmed-meshheading:2355541-Celiac Disease,
pubmed-meshheading:2355541-Diabetes Mellitus,
pubmed-meshheading:2355541-Gastric Inhibitory Polypeptide,
pubmed-meshheading:2355541-Humans,
pubmed-meshheading:2355541-Hypoglycemia,
pubmed-meshheading:2355541-Pancreatitis,
pubmed-meshheading:2355541-Radioimmunoassay
|
pubmed:year |
1990
|
pubmed:articleTitle |
[Plasma gastric inhibitory polypeptide assay and the clinical significance].
|
pubmed:affiliation |
Third Department of Internal Medicine, Tohoku University School of Medicine.
|
pubmed:publicationType |
Journal Article
|